Why the study?
Many patients with CAD have a reduced effect of aspirin, which may partly be explained by immature platelets, but whether immature platelet markers can predict cardiovascular events was unclear.
Do immature platelet markers predict cardiovascular events in patients with stable coronary artery disease?
Do immature platelet markers predict cardiovascular events in patients with stable coronary artery disease?
Immature platelet markers measured in the stable phase do not predict future cardiovascular events in patients with stable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Immature platelet markers were not associated with events in stable CAD; leaves open their prognostic value and does not support routine use.
Pedersen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: